Screening for and early detection of chronic obstructive pulmonary disease

Joan B Soriano, Jan Zielinski, David Price

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.
Original languageEnglish
Pages (from-to)721-732
Number of pages12
JournalThe Lancet
Volume374
Issue number9691
DOIs
Publication statusPublished - 29 Aug 2009

Keywords

  • algorithms
  • cost of illness
  • diagnostic errors
  • early diagnosis
  • Finland
  • forced expiratory volume
  • Great Britain
  • humans
  • mass screening
  • Poland
  • population surveillance
  • prevalence
  • primary prevention
  • pulmonary disease, chronic obstructive
  • risk factors
  • risk reduction behavior
  • secondary prevention
  • severity of illness index
  • smoking cessation
  • spirometry
  • tertiary prevention
  • vital capacity
  • world health

Cite this

Screening for and early detection of chronic obstructive pulmonary disease. / Soriano, Joan B; Zielinski, Jan; Price, David.

In: The Lancet, Vol. 374, No. 9691, 29.08.2009, p. 721-732.

Research output: Contribution to journalArticle

Soriano, Joan B ; Zielinski, Jan ; Price, David. / Screening for and early detection of chronic obstructive pulmonary disease. In: The Lancet. 2009 ; Vol. 374, No. 9691. pp. 721-732.
@article{dfea585aea314f15b37ad7e639516852,
title = "Screening for and early detection of chronic obstructive pulmonary disease",
abstract = "Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.",
keywords = "algorithms, cost of illness, diagnostic errors, early diagnosis, Finland, forced expiratory volume, Great Britain, humans, mass screening, Poland, population surveillance, prevalence, primary prevention, pulmonary disease, chronic obstructive, risk factors, risk reduction behavior, secondary prevention, severity of illness index, smoking cessation, spirometry, tertiary prevention, vital capacity, world health",
author = "Soriano, {Joan B} and Jan Zielinski and David Price",
year = "2009",
month = "8",
day = "29",
doi = "10.1016/S0140-6736(09)61290-3",
language = "English",
volume = "374",
pages = "721--732",
journal = "The Lancet",
issn = "0140-6736",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "9691",

}

TY - JOUR

T1 - Screening for and early detection of chronic obstructive pulmonary disease

AU - Soriano, Joan B

AU - Zielinski, Jan

AU - Price, David

PY - 2009/8/29

Y1 - 2009/8/29

N2 - Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.

AB - Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.

KW - algorithms

KW - cost of illness

KW - diagnostic errors

KW - early diagnosis

KW - Finland

KW - forced expiratory volume

KW - Great Britain

KW - humans

KW - mass screening

KW - Poland

KW - population surveillance

KW - prevalence

KW - primary prevention

KW - pulmonary disease, chronic obstructive

KW - risk factors

KW - risk reduction behavior

KW - secondary prevention

KW - severity of illness index

KW - smoking cessation

KW - spirometry

KW - tertiary prevention

KW - vital capacity

KW - world health

U2 - 10.1016/S0140-6736(09)61290-3

DO - 10.1016/S0140-6736(09)61290-3

M3 - Article

VL - 374

SP - 721

EP - 732

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9691

ER -